Latest Breaking News On - Lightpoint medical - Page 1 : comparemela.com

Up 74% in 6 months, guess which ASX 200 healthcare stock just hit another all-time high

Up 74% in 6 months, guess which ASX 200 healthcare stock just hit another all-time high
fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.

South australiaUnited statesShane fitzgeraldAustralian bureau of statisticsTelix pharmaceuticalsTelix pharmaceuticals ltdDrug administrationAustralian bureauLightpoint medicalUnited states foodInvestor shane fitzgerald

Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS

Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan antonioUnited kingdomChristian behrenbruchCaroline rousseauKyahn williamsonAustralian therapeutic goods administrationAmerican cancer societyWorld cancer research fundHealth canadaCorporate communicationsAustralian securities exchangeTelix pharmaceuticalsPrnewswire telix pharmaceuticals limitedDrug administrationPharmaceuticals limited

Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces positive topline results from the Phase II OPALESCENCE.

United statesUnited kingdomSan antonioChristian behrenbruchCaroline rousseauKyahn williamsonHealth canadaCorporate communicationsAmerican cancer societyWorld cancer research fundAustralian therapeutic goods administrationDrug administrationPrnewswire telix pharmaceuticals limitedAustralian securities exchangeTelix pharmaceuticalsPharmaceuticals limited

Positive Topline Results from Phase II OPALESCENCE Study of TLX250-CDx in Triple Negative Breast Cancer Presented at SABCS

/PRNewswire/ Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) announces positive topline results from the Phase II OPALESCENCE.

San antonioUnited statesUnited kingdomCaroline rousseauChristian behrenbruchKyahn williamsonPrnewswire telix pharmaceuticals limitedDrug administrationTelix pharmaceuticalsAustralian securities exchangeHealth canadaCorporate communicationsWorld cancer research fundAmerican cancer societyAustralian therapeutic goods administrationPharmaceuticals limited

Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery

13.11.2023 - Regulatory News: Telix Pharmaceuticals Limited (ASX: TLX, Telix) and Mauna Kea Technologies (Euronext Growth: ALMKT, Mauna Kea), today announced an expansion of the IRiS (Imaging and Robotics in Surgery) Alliance through a strategic €6 million . Seite 1

Cdx illuccixMauna kea cellvizioDedicaid gmbMauna keaDrug administrationTelix pharmaceuticals limitedHealth canadaRobotics in surgery allianceAustralian therapeutic goods administrationRegulatory newsPharmaceuticals limitedMauna kea technologiesEuronext growthLightpoint medicalDedicaid gmbhMauna kea technologieso chart